Categories AlphaGraphs, Earnings, Health Care

Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today.

Revenues decreased 20% year-over-year to $14.8 billion.

Reported net income declined 44% to $3.1 billion, or $0.55 per share, compared to last year. Adjusted EPS fell 33% to $0.82.

Revenue and earnings beat estimates, allowing the stock to gain over 2% in premarket hours on Wednesday.

For the full year of 2024, revenues are expected to range between $58.5-61.5 billion. Adjusted EPS is expected to range between $2.15-2.35.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Key metrics from Biogen’s (BIIB) Q4 2024 earnings results

Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion.   Net income attributable to Biogen Inc. was $266.8 million,

Important takeaways from Coca-Cola’s (KO) Q4 2024 earnings

The Coca-Cola Company (NYSE: KO) has wrapped up fiscal 2024 on an upbeat note, reporting stronger-than-expected results for the final quarter of the year. Encouraged by the growth in sales

Walt Disney (DIS): A look at the performance of the streaming business in 1Q25

Shares of The Walt Disney Company (NYSE: DIS) dropped 1% on Tuesday. The stock has gained 6% over the past three months. The company delivered top and bottom line growth

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close